SWM
NVO

Sanctuary Wealth Management’s Novo Nordisk NVO Stock Holding History

Sanctuary Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.29K Hold
15
– – ﹤0.01% 248
2024
Q3 		$1.79K Hold
15
– – ﹤0.01% 236
2024
Q2 		$2.14K Buy
+15
New +$1.99K ﹤0.01% 212

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Sanctuary Wealth Management's NVO Position: Q4 2024 in Review

Sanctuary Wealth Management held its Novo Nordisk (NVO) position steady in Q4 2024 at 15 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #248.

Sanctuary Wealth Management first reported a position in NVO in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.14K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sanctuary Wealth Management held 15 shares of Novo Nordisk worth $1.29K as of Q4 2024.
  • Sanctuary Wealth Management left its Novo Nordisk share count unchanged in Q4 2024.
  • Novo Nordisk made up ﹤0.01% of Sanctuary Wealth Management's portfolio in Q4 2024, its #248 holding.
  • Sanctuary Wealth Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 3 quarters since.
  • Sanctuary Wealth Management's Novo Nordisk position peaked at $2.14K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.